Candriam Equities L Oncology Impact R/ LU1864482788 /
| NAV16/05/2024 | Chg.+0.2700 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 286.8900USD | +0.09% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.01 | - |
| 2019 | 10.23 | 6.17 | 2.65 | -3.66 | -2.58 | 8.68 | 0.29 | -0.29 | -3.18 | 5.10 | 7.95 | 5.04 | +41.40% |
| 2020 | -1.47 | -5.35 | -3.08 | 12.11 | 8.53 | 1.41 | 4.42 | 2.15 | 3.51 | -2.22 | 5.80 | 3.86 | +32.31% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.57 | -3.78 | 3.37 | -6.38 | 3.98 | +3.33% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.03 | 4.36 | -3.15 | -4.72 | 7.04 | 6.06 | -3.45 | -9.77% |
| 2023 | 2.15 | -3.89 | 1.38 | 2.82 | -2.57 | 0.08 | 0.88 | -2.03 | -5.25 | -6.37 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.13 | 1.49 | -3.39 | 5.00 | - | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 10.88% | 10.93% | 11.81% | 14.68% | 17.25% |
| Ratio de Sharpe | 1.96 | 3.50 | 0.28 | -0.15 | 0.39 |
| Le meilleur mois | +5.72% | +9.21% | +9.21% | +9.21% | +12.11% |
| Le plus défavorable mois | -3.39% | -3.39% | -6.37% | -10.50% | -10.50% |
| Perte maximale | -6.78% | -6.78% | -15.93% | -25.23% | -25.23% |
| Surperformance | - | - | - | - | - |
Toutes les cotations dans USD
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,400.9099 | +7.62% | +6.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,565.5000 | +7.75% | +6.45% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.9700 | +4.02% | -4.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.5000 | +5.81% | +17.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.3000 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.4500 | +6.23% | +14.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2900 | +6.27% | +2.13% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3300 | +7.17% | +4.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,796.0000 | +3.23% | +2.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.3600 | +5.69% | +16.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,114.3201 | +5.00% | -2.15% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.0600 | +7.14% | +17.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.4600 | +3.60% | -5.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.8900 | +7.16% | +4.72% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.1900 | +4.88% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,857.8800 | +6.15% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,884.1399 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.5300 | +6.26% | +2.11% |
Performance
| CAD | +8.65% | ||
|---|---|---|---|
| 6 Mois | +19.01% | ||
| 1 An | +7.16% | ||
| 3 Ans | +4.72% | ||
| 5 Ans | +65.33% | ||
| 10 ans | - | ||
| Depuis le début | +91.26% | ||
| Année | |||
| 2023 | +1.01% | ||
| 2022 | -9.77% | ||
| 2021 | +3.33% | ||
| 2020 | +32.31% | ||
| 2019 | +41.40% | ||
